American Society for Clinical Pharmacology and Therapeutics (ASCPT)

The American Society for Clinical Pharmacology and Therapeutics (ASCPT) was founded in 1900, and consists of over 3,000 professionals whose primary interest is to advance the science and practice of clinical pharmacology and translational science for the therapeutic benefit of patients and society. ASCPT is the largest scientific and professional organization serving the disciplines of clinical pharmacology and translational science. 

ASCPT focuses on improving the understanding and use of existing drug therapies and developing safer and more effective treatments for the future. Our memberships' unique combination of scientific and clinical expertise makes them especially qualified to understand the impact of disease on patients, the compelling need for effective drug therapy, and the efforts necessary to meet those needs. Such efforts include research, exchange of scientific information, and awareness of legislative requirements that affect drug development and regulation. 

Mission:
Advancing clinical pharmacology, translational science, and therapeutics for the benefit of all patients and society.

Vision:
ASCPT is the global catalyst for excellence in clinical translational pharmacology, shaping therapeutic innovation and treatment optimization for every patient.

Strategic Plan
The Society's strategic plan for 2026 through 2030 focuses on three pillars of Science, People, and Influence.